Literature DB >> 23825778

Percutaneous coronary intervention, a historical perspective looking to the future.

Johan Bennett1, Christophe Dubois.   

Abstract

Year:  2013        PMID： 23825778      PMCID： PMC3698257          DOI： 10.3978/j.issn.2072-1439.2013.04.21

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  26 in total

1.  Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution.

Authors:  J J Wentzel; D M Whelan; W J van der Giessen; H M van Beusekom; I Andhyiswara; P W Serruys; C J Slager; R Krams
Journal:  J Biomech       Date:  2000-10       Impact factor: 2.712

2.  Healing Achilles--sirolimus versus paclitaxel.

Authors:  David J Moliterno
Journal:  N Engl J Med       Date:  2005-08-16       Impact factor: 91.245

Review 3.  Coronary-artery stents.

Authors:  Patrick W Serruys; Michael J B Kutryk; Andrew T L Ong
Journal:  N Engl J Med       Date:  2006-02-02       Impact factor: 91.245

4.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.

Authors:  Patrick W Serruys; John A Ormiston; Yoshinobu Onuma; Evelyn Regar; Nieves Gonzalo; Hector M Garcia-Garcia; Koen Nieman; Nico Bruining; Cécile Dorange; Karine Miquel-Hébert; Susan Veldhof; Mark Webster; Leif Thuesen; Dariusz Dudek
Journal:  Lancet       Date:  2009-03-14       Impact factor: 79.321

5.  Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.

Authors:  Giulio G Stefanini; Robert A Byrne; Patrick W Serruys; Antoinette de Waha; Bernhard Meier; Steffen Massberg; Peter Jüni; Albert Schömig; Stephan Windecker; Adnan Kastrati
Journal:  Eur Heart J       Date:  2012-03-24       Impact factor: 29.983

6.  Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

Authors:  Gregg W Stone; Ali Rizvi; William Newman; Kourosh Mastali; John C Wang; Ronald Caputo; Julie Doostzadeh; Sherry Cao; Charles A Simonton; Krishnankutty Sudhir; Alexandra J Lansky; Donald E Cutlip; Dean J Kereiakes
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

7.  Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.

Authors:  Martin B Leon; Eugenia Nikolsky; Donald E Cutlip; Laura Mauri; Henry Liberman; Hadley Wilson; John Patterson; Jeffrey Moses; David E Kandzari
Journal:  JACC Cardiovasc Interv       Date:  2010-10       Impact factor: 11.195

8.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

Authors:  W J van der Giessen; A M Lincoff; R S Schwartz; H M van Beusekom; P W Serruys; D R Holmes; S G Ellis; E J Topol
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

9.  Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Michael J Attubato; Frederick Feit; Deepak L Bhatt; James Slater
Journal:  Circulation       Date:  2012-05-14       Impact factor: 29.690

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983
View more
  2 in total

1.  Overview of Technical and Cost Considerations in Complex Percutaneous Coronary Intervention.

Authors:  J Raider Estrada; Jonathan D Paul; Atman P Shah; Sandeep Nathan
Journal:  Interv Cardiol       Date:  2014-03

2.  Applying DESyne coronary stent system in patients with ischemic heart disease: experience from Jordan.

Authors:  Mohamad I Jarrah; Nasr Alrabadi; Karem H Alzoubi
Journal:  Med Devices (Auckl)       Date:  2018-11-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.